{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:15:29Z","timestamp":1775063729260,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.atherosclerosis.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T08:24:25Z","timestamp":1218615865000},"page":"479-482","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: A multicenter, randomized, double-blind clinical trial"],"prefix":"10.1016","volume":"203","author":[{"given":"Manoela F.B.","family":"Braga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.A.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avery L.","family":"Teplinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislaine","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale J.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","article-title":"Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham study","volume":"74","author":"Kannel","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib2","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.256.20.2823","article-title":"Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)","volume":"256","author":"Stamler","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib4","doi-asserted-by":"crossref","unstructured":"Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association Conference on Scientific Issues related to definition. Circulation 2004;109:433\u20138.","DOI":"10.1161\/01.CIR.0000111245.75752.C6"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","article-title":"Canadian Cardiovascular Society, Canadian Cardiovascular Society position statement\u2013recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003495-198427020-00001","article-title":"Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy","volume":"27","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)61815-1","article-title":"Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis","volume":"69","author":"Balan","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.1840170408","article-title":"Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib9","doi-asserted-by":"crossref","unstructured":"American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82\u201396.","DOI":"10.1161\/CIRCULATIONAHA.106.176158"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2362.1980.tb00040.x","article-title":"Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids","volume":"10","author":"Maton","year":"1980","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0016-5085(19)30493-7","article-title":"Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans","volume":"78","author":"Salen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF02536997","article-title":"Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding","volume":"30","author":"Bouscarel","year":"1995","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0016-5085(80)90567-3","article-title":"Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration","volume":"78","author":"Ponz de Leon","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib14","first-page":"632","article-title":"Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial","volume":"204","author":"Cabezas Gelabert","year":"2004","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.atherosclerosis.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/gut.44.4.552","article-title":"Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans","volume":"44","author":"Lanzarotto","year":"1999","journal-title":"Gut"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500800542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500800542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T08:41:03Z","timestamp":1557736863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191500800542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S002191500800542X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.08.001","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}